NO20064978L - Farmasoytisk preparat inneholdende drospirenon for paforing pa huden - Google Patents

Farmasoytisk preparat inneholdende drospirenon for paforing pa huden

Info

Publication number
NO20064978L
NO20064978L NO20064978A NO20064978A NO20064978L NO 20064978 L NO20064978 L NO 20064978L NO 20064978 A NO20064978 A NO 20064978A NO 20064978 A NO20064978 A NO 20064978A NO 20064978 L NO20064978 L NO 20064978L
Authority
NO
Norway
Prior art keywords
drospirenone
pharmaceutical preparation
preparation containing
skin application
skin
Prior art date
Application number
NO20064978A
Other languages
English (en)
Inventor
Stefan Bracht
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20064978L publication Critical patent/NO20064978L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Foreliggende oppfinnelse gjelder et farmasøytisk preparat inneholdende drospirenon for påføring på huden. Mengden av drospirenon som inngår i preparatet i utgangstilstanden, overskrider ikke metningsløseligheten. Når preparatet påføres huden, overskrides imidlertid metningsløseligheten av drospirenon. Det farmasøytiske preparat muliggjør blant annet ttansdermal tilførsel av effektivt befiiiktningshindrende mengder av drospirenon.
NO20064978A 2004-04-01 2006-10-31 Farmasoytisk preparat inneholdende drospirenon for paforing pa huden NO20064978L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004016779A DE102004016779A1 (de) 2004-04-01 2004-04-01 Drospirenonhaltige Zubereitungen zur transdermalen Anwendung
PCT/EP2005/002971 WO2005097196A2 (de) 2004-04-01 2005-03-19 Pharmazeutische zubereitung zur applikation auf die haut mit einem gehalt an drospirenon

Publications (1)

Publication Number Publication Date
NO20064978L true NO20064978L (no) 2006-10-31

Family

ID=34977050

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064978A NO20064978L (no) 2004-04-01 2006-10-31 Farmasoytisk preparat inneholdende drospirenon for paforing pa huden

Country Status (17)

Country Link
EP (1) EP1729778B1 (no)
JP (1) JP2007530615A (no)
KR (1) KR100832157B1 (no)
CN (1) CN1933843A (no)
AT (1) ATE397935T1 (no)
AU (1) AU2005231582A1 (no)
BR (1) BRPI0509585A (no)
CA (1) CA2558349A1 (no)
CR (1) CR8632A (no)
DE (2) DE102004016779A1 (no)
EA (1) EA200601818A1 (no)
EC (1) ECSP066900A (no)
ES (1) ES2307154T3 (no)
IL (1) IL177938A0 (no)
NO (1) NO20064978L (no)
WO (1) WO2005097196A2 (no)
ZA (1) ZA200609079B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090181075A1 (en) * 2005-07-15 2009-07-16 Gordon Ryan D Drospirenone containing transdermal drug delivery devices and methods of delivery thereof
WO2010008600A1 (en) * 2008-07-16 2010-01-21 Dermworx Incorporated Topical drug delivery system
US9241944B2 (en) 2010-06-16 2016-01-26 Institut National De La Santé Et De La Recherche Médicale (Inserm) Methods and compositions for stimulating reepithelialisation during wound healing
CN108606963B (zh) * 2017-12-27 2021-05-18 上海长海医院 含有屈螺酮和雌激素的复方避孕贴、制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU610839B2 (en) * 1986-11-07 1991-05-30 Purepac, Inc Transdermal administration of amines
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
DE19651000A1 (de) 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone
DE19906152B4 (de) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
MEP35908A (en) * 2002-04-26 2011-02-10 Bayer Schering Pharma Ag Treatment of hypertension in women receiving hormone replacement therapy

Also Published As

Publication number Publication date
ES2307154T3 (es) 2008-11-16
WO2005097196A2 (de) 2005-10-20
IL177938A0 (en) 2006-12-31
JP2007530615A (ja) 2007-11-01
DE102004016779A1 (de) 2006-01-19
ATE397935T1 (de) 2008-07-15
KR20060132983A (ko) 2006-12-22
CR8632A (es) 2007-06-06
EA200601818A1 (ru) 2007-04-27
CN1933843A (zh) 2007-03-21
KR100832157B1 (ko) 2008-05-23
EP1729778B1 (de) 2008-06-11
ECSP066900A (es) 2006-12-20
WO2005097196A3 (de) 2006-06-01
DE502005004403D1 (de) 2008-07-24
EP1729778A2 (de) 2006-12-13
AU2005231582A1 (en) 2005-10-20
ZA200609079B (en) 2009-04-29
CA2558349A1 (en) 2005-10-20
BRPI0509585A (pt) 2007-10-09

Similar Documents

Publication Publication Date Title
EA201000089A1 (ru) Применение гомо- и сополимеров для стабилизации составов активных ингредиентов
ATE437679T1 (de) Wässrige antitranspirant formulierung
AR068369A1 (es) Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina"
WO2006119283A3 (en) Anti-odor compositions and therapeutic use
AR047928A1 (es) Derivados de tetrahidropiridoindol
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
CL2008000593A1 (es) Uso de compuestos derivados de heterociclos sustituidos; composicion farmaceutica que comprende a dichos compuestos y otros agentes activos; y su uso para tratar diabetes, enfermedad aterosclerotica de las arterias entre otras enfermedades.
DK1973539T3 (da) Anvendelse af benzokondenserede heterocykliske sulfamidderivater til behandling af depression
TW200740429A (en) Methods and dosage forms for reducing side effects of carbamate compounds
TW200724166A (en) Wrinkle-improving agent
EA201000391A1 (ru) Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция
ATE505083T1 (de) Fungizide mischungen
NO20064978L (no) Farmasoytisk preparat inneholdende drospirenon for paforing pa huden
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent
BRPI0519006A2 (pt) uso de um inibidor de fbpase, kit de uma composiÇço farmacÊutica, uso de uma preparaÇço de biguanida e um inibidor de fbpase, agente terapÊutico para diabetes melito, e, combinaÇço de agentes terapÊuticos
HK1111924A1 (en) Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient
WO2008099906A1 (ja) 歯周病、及び外科手術による歯槽骨欠損の治療剤
DE112006002041A5 (de) Pharmazeutisch wirksame Zusammensetzung zur Behandlung von Diabetes
CL2007002359A1 (es) Compuestos derivados de arilpiperazina; composicion farmaceutica; y uso para tratar la depresion, ansiedad o una combinacion de ambas.
WO2007138233A3 (fr) Utilisation du zatosetron pour le traitement de la rosacee
UY30864A1 (es) Solucion coloidal
WO2005082336A3 (de) Kit aus einem gegebenenfalls wirkstoffhaltigen pflaster und einem hautirritationen verhindernden mittel
WO2009044787A1 (ja) テノモジュリンを有効成分とする腱断裂性疾患治療剤
WO2008000454A8 (en) Composition for the treatment of skin comprising ink sack liquid of cephalopods
JO2608B1 (en) Use of different sulfamide derivatives combined with benzo ring to treat depression

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application